2020
DOI: 10.1016/bs.mie.2020.04.018
|View full text |Cite
|
Sign up to set email alerts
|

Selective protein N-terminal labeling with N-hydroxysuccinimide esters

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(19 citation statements)
references
References 94 publications
0
19
0
Order By: Relevance
“…Fluorescent labeling and GMP-PNP loading of KRAS for microscale thermophoresis studies. KRAS was labeled with Alexa Fluor 647 at its amino terminus following the protocol described in Jiang et al 37 Briefly, to expose the N-terminal cysteine residue, the His6 tag was removed by TEV protease. During the cleavage procedure, a 'one-pot' reaction with MESNA (Sodium 2mercaptoenthanesulfonate, Sigma Aldrich M1511) and Alexa Fluor TM 647 NHS Ester (Invitrogen cat# A20006) was initiated.…”
Section: Preparation Of Kras Proteinsmentioning
confidence: 99%
“…Fluorescent labeling and GMP-PNP loading of KRAS for microscale thermophoresis studies. KRAS was labeled with Alexa Fluor 647 at its amino terminus following the protocol described in Jiang et al 37 Briefly, to expose the N-terminal cysteine residue, the His6 tag was removed by TEV protease. During the cleavage procedure, a 'one-pot' reaction with MESNA (Sodium 2mercaptoenthanesulfonate, Sigma Aldrich M1511) and Alexa Fluor TM 647 NHS Ester (Invitrogen cat# A20006) was initiated.…”
Section: Preparation Of Kras Proteinsmentioning
confidence: 99%
“…The affinity tag will typically be cleaved with either TEV or SUMO protease, exposing an N‐terminal Cys, which should be introduced adjacent to the C‐terminus of the tag. In practice, the labeling strategy using NHS esters can be performed in two slightly different ways: a stepwise procedure (Dempsey, Jiang, Kalin, Chen, & Cole, 2018), described in Basic Protocol 1, or a one‐pot approach (Jiang, D'Agostino, Cole, & Dempsey, 2020), described in Alternate Protocol. In the stepwise procedure, cleavage of the N‐terminal affinity tag is carried out before labeling.…”
Section: Strategic Planningmentioning
confidence: 99%
“…The versatility of this technology was further explored by labeling a 130 kDa ubiquitin carboxyl-terminal hydrolase 7 (USP7) with a readily available sulfo-cyanine5-NHS ester moiety. [73] It is noteworthy that this reaction is biocompatible. In addition, the ready availability of different commercially accessible functional NHS esters makes the whole technique versatile and cost-effective.…”
Section: Thioester Derivativesmentioning
confidence: 97%
“…The resulting conjugate then undergoes an intramolecular S-to-N acyl shift to form a native isopeptide bond, [37] resulting in the ligation of the two peptides (Figure 7A). In the N-hydroxy succinimide (NHS) ester labeling approach, [72,73] by employing a principle similar to that of NCL, the NHS ester is first pretreated with mercaptoethane sulfonate (Figure 7B). This small thiol converts the NHS ester into a chemoselective thioester, which in turn, can be reacted in situ with N-terminal cysteine, to yield a native amide bond.…”
Section: Thioester Derivativesmentioning
confidence: 99%
See 1 more Smart Citation